Cargando…

Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical Prostatectomy

The multifocal nature of prostate cancer (PCa) creates a challenge to patients’ outcome prediction and their clinical management. An approach that scrutinizes every cancer focus is needed in order to generate a comprehensive evaluation of the disease, and by correlating to patients’ clinico-patholog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ibeawuchi, Chinyere, Schmidt, Hartmut, Voss, Reinhard, Titze, Ulf, Abbas, Mahmoud, Neumann, Joerg, Eltze, Elke, Hoogland, Agnes Marije, Jenster, Guido, Brandt, Burkhard, Semjonow, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346930/ https://www.ncbi.nlm.nih.gov/pubmed/25679447 http://dx.doi.org/10.3390/ijms16023856

Ejemplares similares

Genome-Wide Investigation of Multifocal and Unifocal Prostate Cancer—Are They Genetically Different?
por: Ibeawuchi, Chinyere, et al.
Publicado: (2013)

Low Numbers of Vascular Vessels Correlate to Progression in Hormone-Naïve Prostate Carcinomas Undergoing Radical Prostatectomy
por: Smentoch, Julia, et al.
Publicado: (2019)

BRCAness in prostate cancer
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2019)

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens
por: Eminaga, Okyaz, et al.
Publicado: (2010)

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer
por: Eminaga, Okyaz, et al.
Publicado: (2012)

PAPSS2 Deficiency Causes Androgen Excess via Impaired DHEA Sulfation—In Vitro and in Vivo Studies in a Family Harboring Two Novel PAPSS2 Mutations
por: Oostdijk, Wilma, et al.
Publicado: (2015)

Prognostic significance of a novel indicator (PSA(postd3)/PSA(pre)) for PSA recurrence in patients after radical prostatectomy
por: Zhou, Zhien, et al.
Publicado: (2019)

Novel Inactivating Homozygous PAPSS2 Mutation in Two Siblings With Disproportionate Short Stature
por: Perez-Garcia, E. Melissa, et al.
Publicado: (2021)

The natural history of a delayed detectable PSA after radical prostatectomy
por: Szymaniak, Julie A., et al.
Publicado: (2023)

The osteoarthritis-associated gene PAPSS2 promotes differentiation and matrix formation in ATDC5 chondrogenic cells
por: Fan, Liying, et al.
Publicado: (2018)

Identification of variants in ACAN and PAPSS2 leading to spondyloepi(meta)physeal dysplasias in four Chinese families
por: Cao, Yixuan, et al.
Publicado: (2022)

EGFR as a stable marker of prostate cancer dissemination to bones
por: Nastały, Paulina, et al.
Publicado: (2020)

PSA mass as a marker of prostate cancer progression after radical prostatectomy
por: Bryniarski, Piotr, et al.
Publicado: (2011)

Heterophilic Antibodies Resulting in False Positive Elevation of PSA After Radical Prostatectomy
por: Asha, Wafa, et al.
Publicado: (2023)

Disease-Related Protein Variants of the Highly Conserved Enzyme PAPSS2 Show Marginal Stability and Aggregation in Cells
por: Brylski, Oliver, et al.
Publicado: (2022)

Low Tumor-to-Stroma Ratio Reflects Protective Role of Stroma against Prostate Cancer Progression
por: Nastały, Paulina, et al.
Publicado: (2021)

PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort
por: Lotan, Tamara L., et al.
Publicado: (2017)

Altered responsiveness to TGF-β results in reduced Papss2 expression and alterations in the biomechanical properties of mouse articular cartilage
por: Ramaswamy, Girish, et al.
Publicado: (2012)

Genome-wide CRISPR screen for HSV-1 host factors reveals PAPSS1 contributes to heparan sulfate synthesis
por: Suzuki, Takeshi, et al.
Publicado: (2022)

Markhor-derived Introgression of a Genomic Region Encompassing PAPSS2 Confers High-altitude Adaptability in Tibetan Goats
por: Li, Chao, et al.
Publicado: (2022)

Early Prediction of Therapy Response to Abiraterone Acetate Using PSA Subforms in Patients with Castration Resistant Prostate Cancer
por: Schlack, Katrin, et al.
Publicado: (2016)

Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer
por: Mikah, Phillip, et al.
Publicado: (2016)

The prognostic potential of alkaline phosphatase and lactic acid dehydrogenase in bmCRPC patients without significant PSA response under enzalutamide
por: Poteska, Renata, et al.
Publicado: (2022)

The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells
por: Sun, Lei, et al.
Publicado: (2023)

Salvage radiotherapy for patients with PSA relapse after radical prostatectomy: a single institution experience
por: Quero, Laurent, et al.
Publicado: (2008)

Undetectable ultrasensitive PSA after radical prostatectomy for prostate cancer predicts relapse-free survival
por: Doherty, A P, et al.
Publicado: (2000)

Comparison of Pathological and Biochemical Outcomes after Radical Prostatectomy in Korean Patients with Serum PSA Ranges
por: Lee, Hye Won, et al.
Publicado: (2015)

Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer
por: Hoogland, A. Marije, et al.
Publicado: (2016)

Loss of SOX9 Expression Is Associated with PSA Recurrence in ERG-Positive and PTEN Deleted Prostate Cancers
por: Burdelski, Christoph, et al.
Publicado: (2015)

Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA >20 ng/mL
por: Hinev, Alexander I., et al.
Publicado: (2012)

HOXB13 overexpression is an independent predictor of early PSA recurrence in prostate cancer treated by radical prostatectomy
por: Zabalza, Cristina Villares, et al.
Publicado: (2015)

Evaluating the Impact of PSA as a Selection Criteria for Nerve Sparing Radical Prostatectomy in a Screened Cohort
por: Tanguturi, Shyam K., et al.
Publicado: (2014)

The effects of PSA kinetics on the outcome of hypofractionated salvage radiotherapy for biochemical recurrence of prostate cancer after prostatectomy
por: Ishikawa, Hitoshi, et al.
Publicado: (2020)

What is the possible role of PSA doubling time (PSADT) and PSA velocity (PSAV) in the decision-making process to initiate salvage radiotherapy following radical prostatectomy in patients with prostate cancer?
por: Milecki, Piotr, et al.
Publicado: (2011)

[−2]proPSA versus ultrasensitive PSA fluctuations over time in the first year from radical prostatectomy, in an high-risk prostate cancer population: A first report
por: De Luca, S., et al.
Publicado: (2016)

PAPSS2 Promotes Alkaline Phosphates Activity and Mineralization of Osteoblastic MC3T3-E1 Cells by Crosstalk and Smads Signal Pathways
por: Wang, Weizhuo, et al.
Publicado: (2012)

Loss of PSP94 expression is associated with early PSA recurrence and deteriorates outcome of PTEN deleted prostate cancers
por: Luebke, Andreas M., et al.
Publicado: (2019)

Down-Regulation of S100A8 is an Independent Predictor of PSA Recurrence in Prostate Cancer Treated by Radical Prostatectomy()
por: Minner, Sarah, et al.
Publicado: (2019)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

Comparison of hypofractionation and standard fractionation for post-prostatectomy salvage radiotherapy in patients with persistent PSA: single institution experience
por: Murgic, Jure, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_12oal6dhi9hild1sqigf226klc